Archive

{source}<div data-configid="5690019/10028657" style="width: 600px; height: 396px;" class="issuuembed"></div><script…

The third batch of the Biocon Academy commenced on 3rd Nov’ at Bangalore

The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011

Fenofibrate capsules are indicated for primary hypercholesterolemia and mixed dyslipidemia. In addition, it is indicated for…

It is a generic version of Prilosec by AstraZeneca

The US FDA Medicare study of 134,000 patients demonstrates benefits such as a significantly reduced risk of ischaemic stroke, a…

Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalisation

Lirusso brings vast experience in films, foils, and ridged plastics and blister packs within the pharmaceutical industry. And…

Biocon will now have the exclusive, region-wide rights to distribute CytoSorb for all critical care applications in the ICU as…

Generic disclosure in the prior art may not necessarily take away the novelty of a specific disclosure Taking into account the…